基于肠道菌群稳态探讨新蒲饮治疗脾胃湿热型幽门螺杆菌相关胃炎的临床疗效OA
Exploration on Clinical Efficacy of Xinpu Decoction in the Treatment of Helicobacter pylori-Associated Gastritis with Spleen-Stomach Damp-Heat Pattern Based on Intestinal Flora Homeostasis
目的 探讨新蒲饮联合二联疗法治疗脾胃湿热型幽门螺杆菌(Hp)感染相关胃炎的临床疗效,以及对肠道微生态的影响.方法 选择符合纳入标准的234例Hp感染慢性胃炎脾胃湿热证患者,依据随机数字表随机分为新蒲饮+二联组(A组,新蒲饮联合二联疗法)、二联组(B组,单纯用二联疗法)及美常安+二联组(C组,枯草杆菌二联活菌胶囊联合二联疗法),每组各78例,治疗过程中3组分别脱落2、1、4例,治疗周期均为14 d.观察治疗后3组患者Hp根除率、中医证候疗效、中医症状总积分及单个症状改善情况,同时于治疗前后随机留取42例患者的新鲜粪便(有患者未提供粪便样本,最终3组分别完成14、13、15例),通过16S rRNA测序技术,分析肠道菌群丰度、多样性等的变化.结果 治疗后3组患者的Hp根除率分别为96.05%、94.81%、95.95%;中医证候有效率分别为98.68%、77.92%、89.12%,新蒲饮+二联组显著高于其他两组(P<0.001),且治疗后的症状评分显著降低(P<0.001),尤其在胃脘痛、胃脘胀满、大便稀溏、肢体困重四个症状改善方面,均优于二联组(P<0.05).物种组成多样性分析中,新蒲饮+二联组治疗后门水平以拟杆菌门、放线菌门丰度高,变形菌门丰度低,属水平以拟杆菌属、普雷沃氏菌属和粪杆菌属丰度高,克雷伯菌属、埃希氏菌-志贺氏菌属的相对丰度较低;通过Lefse分析,筛选到显著富集的物种为丁酸单胞菌属,阿德勒克氏菌属,进一步功能预测分析发现功能富集的通路为牛磺酸和亚牛磺酸代谢、类固醇激素合成通路.而二联组治疗后未发现显著富集的物种,亦未发现菌群功能富集的差异通路.美常安+二联组治疗后显著富集的物种为粪球菌属,富集的通路为脂多糖合成、戊糖和葡萄糖醛酸的相互转化等.结论 新蒲饮联合二联疗法治疗脾胃湿热型Hp相关胃炎,有较高的Hp根除率,临床症状改善显著,其治疗机制可能是促进细菌代谢产物丁酸生成,增加有益菌数量,抑制条件致病菌生长,恢复肠道无氧状态,进而调控肠道菌群稳态.
Objective To explore the clinical efficacy of Xinpu Decoction combined with dual therapy in the treatment of Helicobacter pylori(Hp)-associated gastritis with spleen-stomach damp-heat pattern and its impact on intestinal microecology.Methods A total of 234 patients of Hp-associated chronic gastritis with spleen-stomach damp-heat pattern who met the inclusion criteria were enrolled.Subsequently,using a random number table,patients were randomly divided into three groups:Xinpu Decoction+dual therapy group(group A,Xinpu Decoction combined with dual therapy),the dual therapy group(group B,Xinpu Decoction combined with dual therapy),and the Bifico+dual therapy group(group C,Live Combined Bacillus subtilis and Enterococcus faecium Capsules),with 78 cases in each group.During the treatment,2,1,and 4 patients dropped out in the three groups,respectively.All patients received treatment for 14 days.After treatment,the Hp eradication rate,traditional Chinese medicine(TCM)syndrome efficacy,total score of TCM symptoms and the improvement of individual symptoms were observed among the three groups.Meanwhile,fresh fecal samples from 42 randomly selected patients were collected before and after this treatment(Due to the failure to provide stool samples,data from only 14,13,and 15 patients in each group were ultimately included in the final analysis),and 16S rRNA sequencing technology was used to analyze the changes in intestinal flora abundance and diversity among the three groups.Results After treatment,the Hp eradication rates of the three groups were 96.05%,94.81%,and 95.95%respectively,and the total effective rates of TCM syndrome after treatment were 98.68%,77.92%,and 89.12%respectively.Xinpu Decoction+dual therapy group showed a significantly higher rate compared to the other groups(P<0.001).Moreover,the symptom scores were significantly reduced(P<0.001).Specifically,improvements in epigastric pain,epigastric distension,loose stools,and somatic heaviness were significantly superior compared to the dual therapy group(P<0.05).In the analysis of species composition diversity,Xinpu Decoction+dual therapy group showed the following characteristics:at the phylum level,the abundances of Bacteroidetes and Actinobacteria were high,while the abundance of Proteobacteria was low;at the genus level,there was high abundance of Bacteroides,Prevotella and Faecalibacterium,while the relative abundances of Klebsiella and Escherichia-Shigella were low.Additionally,through Lefse analysis,the significantly enriched species were identified as Butyricimonas and Adlercreutzia.Further functional prediction analysis revealed that the functionally enriched pathways were taurine and hypotaurine metabolism,and steroid hormone biosynthesis pathways.In the dual therapy group,no significantly enriched species were found after treatment,so no differential pathways with enriched flora functions were observed between pre-and post-treatment.In the Bifico+dual therapy group,the significantly enriched species after treatment was Coprococcus,and the enriched pathways included lipopolysaccharide biosynthesis,interconversion of pentose and glucuronate,etc.Conclusion Xinpu Decoction combined with dual therapy in the treatment of Hp-associated gastritis with spleen-stomach damp-heat pattern shows a high Hp eradication rate and significant improvement in clinical symptoms.Its therapeutic mechanism may be as follows:promoting the production of butyric acid,increasing the number of beneficial bacteria,inhibiting the growth of conditional pathogens,restoring the anaerobic state of the intestine,and thereby regulating the homeostasis of intestinal flora.
刘智群;李璐吉;杨勤;金小晶;缪伟峰
南京中医药大学附属南京中医院,江苏 南京 210000南京中医药大学附属南京中医院,江苏 南京 210000南京中医药大学附属南京中医院,江苏 南京 210000南京中医药大学附属南京中医院,江苏 南京 210000南京中医药大学附属南京中医院,江苏 南京 210000
新蒲饮幽门螺杆菌胃炎脾胃湿热证临床疗效肠道菌群16S rRNA测序
Xinpu DecoctionHelicobacter pylori gastritisSpleen-stomach damp-heat patternClinical efficacyIntestinal flora16S rRNA sequencing
《中医药信息》 2026 (10)
43-52,10
江苏省中医药学会振兴发展项目(ZXFZ2024019)南京市中医药传承创新发展示范试点资助项目(NJCC-ZJ-202416)南京市中医院院内制剂研究备案项目(ZJ2022011)杨勤名中医工作室(2023-NJSMZYGZS-YQ)
评论